People Background Check
Find People:

Kambiz Thomas Moazed, Age 752000 Broadway UNIT 14F, New York, NY 10023

Get Report
Known as:
Kambiz T Moazed Kambiz Dr Moazed Kambiz D Moazed Doris K Moazed Mohamad Moazed Moazed T Kambiz Moazed Kt

Kambiz Moazed Phones & Addresses

2000 Broadway APT 14F, New York, NY 10023 (646) 505-9632

2000 Broadway, New York, NY 10023

106 85Th St, New York, NY 10028 (212) 535-3789

Sayville, NY

San Francisco, CA

Menlo Park, CA

Babylon, NY

Quincy, MA

702 Sand Hill Cir, Menlo Park, CA 94025 (650) 854-1846

Show more

Work

Position: Medical Professional

Education

School / High School: Ahwaz University School of Medicine / Shahid Chamran University

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Ophthalmology, 1983

Mentions for Kambiz Thomas Moazed

Career records & work history

Medicine Doctors

Kambiz Moazed Photo 1

Dr. Kambiz T Moazed, New York NY - MD (Doctor of Medicine)

Specialties:
Ophthalmology
Address:
21 E 22Nd St, New York, NY 10010
(212) 460-7800 (Phone) (212) 460-7877 (Fax)
2465 Broadway, New York, NY 10025
(212) 712-1000 (Phone) (917) 441-3189 (Fax)
4337 Broadway, New York, NY 10033
(212) 568-6300 (Phone) (212) 544-5079 (Fax)
Certifications:
Ophthalmology, 1983
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Ahwaz University School of Medicine / Shahid Chamran University
Medical School
Stanford U Med Ctr
Medical School
Fell Harvard U Mass Ee Infi
Medical School
Harvard U Mass Ee Infirm
Medical School
Edward Harkness Eye Inst

Kambiz Moazed

Specialties:
Ophthalmology
Work:
AdvantageCare Physicians
21 E 22 St Frnt 1, New York, NY 10010
(212) 460-7800 (phone) (212) 460-7877 (fax)
Site
Education:
Medical School
Ahwaz Univ of Med Sci & Hlth Serv, Ahwaz Med Sch, Ahwaz, Iran
Graduated: 1974
Procedures:
Corneal Surgery, Lens and Cataract Procedures, Ophthalmological Exam
Conditions:
Acute Conjunctivitis, Cataract, Diabetic Retinopathy, Glaucoma, Keratitis, Macular Degeneration, Primary Angle-Closure Glaucoma, Retinal Detachments
Languages:
English, French, Spanish
Description:
Dr. Moazed graduated from the Ahwaz Univ of Med Sci & Hlth Serv, Ahwaz Med Sch, Ahwaz, Iran in 1974. He works in New York, NY and specializes in Ophthalmology. Dr. Moazed is affiliated with Mount Sinai Beth Israel.
Kambiz Moazed Photo 2

Kambiz Thomas Moazed, New York NY

Specialties:
Ophthalmology
Surgery
Work:
Manhattan's Physician Group
21 E 22Nd St, New York, NY 10010Manhattan's Physician Group
4337 Broadway, New York, NY 10033Ophth Dpt.
506 Malcolm X Blvd, New York, NY 10037
Education:
Jundi-Shapour University (Iran *
Massachusetts Eye And Ear Infirmary *Ophthalmology
Stanford Hospital and Clinics *Ophthalmology
Massachusetts Eye And Ear Infirmary *Ophthalmology
New York Presbyterian Hospital / Columbia *Ophthalmology
Kambiz Moazed Photo 3

Kambiz Thomas Moazed, New York NY

Specialties:
Ophthalmologist
Address:
2465 Broadway, New York, NY 10025
21 E 22Nd St, New York, NY 10010
1111 Amsterdam Ave, New York, NY 10025
Education:
Ahvaz Jondishapour University of Medical Sciences - Doctor of Medicine
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology

License Records

Kambiz T Moazed

Address:
2000 Broadway, New York, NY
Phone:
(646) 784-4184
Licenses:
License #: 95039 - Active
Category: Health Care
Issued Date: Jan 10, 2006
Effective Date: Nov 13, 2014
Expiration Date: Jan 31, 2018
Type: Medical Doctor

Kambiz Moazed resumes & CV records

Resumes

Kambiz Moazed Photo 10

Ophthalmology Surgical Attending

Location:
New York, NY
Industry:
Biotechnology
Work:
Lenox Hill Hospital
Ophthalmology Surgical Attending Advantagecare Physicians
Ophthalmic Surgeon Cambyses Biomedical
Founder and President Manhattan's Physician Group
Ophthalmologist
Education:
Columbia University In the City of New York 1982 - 1983
Harvard University 1978 - 1982
Harvard University 1979 - 1982
Harvard University 1978 - 1979
Stanford University 1977 - 1978
Stanford University 1976 - 1977
Skills:
Cataract Surgery, Laser Surgery, Ophthalmology, General Surgery, Oculoplastic Surgery, Nanomedicine, Medicine, Hospitals, Clinical Research, Surgery, Molecular Microbiology, Clinical Trials, Reconstructive Surgery, Healthcare, Healthcare Management, Board Certified, Biomedical Engineering, Laser, Ophthalmic Pathology
Interests:
Science and Technology
Education
Health
Languages:
English
Farsi
German
Kambiz Moazed Photo 11

Medical Doctor

Location:
New York, NY
Industry:
Biotechnology
Work:
Cambyses Biomedical
Medical Doctor
Kambiz Moazed Photo 12

Medical Doctor

Location:
New York, NY
Industry:
Medical Practice
Work:
Manhattan's Physicians Group
MD

Publications & IP owners

Us Patents

Transnasal Lacrimal Insert

US Patent:
2002003, Mar 14, 2002
Filed:
May 22, 2001
Appl. No.:
09/862744
Inventors:
Kambiz Moazed - New York NY, US
International Classification:
A61M005/00
US Classification:
604/008000
Abstract:
A temporary transnasal lacrimal insert is used in a surgical procedure for improving drainage from a patient's lacrimal sac to his or her nasal cavity. The insert includes a tubular member with a proximal end and an enlarged distal end. The insert also includes an attachment element about which ends of a silastic tube can be fastened. In the procedure, a hole is created extending from the lacrimal sac into the nasal cavity using surgical techniques or a laser probe. Then, opposite ends of a silastic tube are introduced through the patient's upper and lower puncta, through the patient's upper and lower canaliculi, through the lacrimal sac, through the hole, and into the nasal cavity. The ends of the silastic tube are then threaded through the passage in the insert. The insert is then placed from the nasal cavity into the hole by forcing the proximal end of the insert through the hole and into the lacrimal sac, and abutting the enlarged distal end, which is larger than the hole, against a surface in the nasal cavity surrounding the hole. The ends of the silastic tube are then fastened to the attachment element of the insert. Excess tube extending into the nasal cavity is then cut short to reduce nasal irritation. After the hole has sufficiently healed in about 3-6 months, the silastic tube and the insert are removed.

Transnasal Lacrimal Insert

US Patent:
2003013, Jul 10, 2003
Filed:
Feb 25, 2003
Appl. No.:
10/373508
Inventors:
Kambiz Moazed - New York NY, US
International Classification:
A61M005/00
US Classification:
604/008000
Abstract:
A temporary transnasal lacrimal insert is used in a surgical procedure for improving drainage from a patient's lacrimal sac to his or her nasal cavity. The insert includes a tubular member with a proximal end and an enlarged distal end. The insert also includes an attachment element about which ends of a silastic tube can be fastened. In the procedure, a hole is created extending from the lacrimal sac into the nasal cavity using surgical techniques or a laser probe. Then, opposite ends of a silastic tube are introduced through the patient's upper and lower puncta, through the patient's upper and lower canaliculi, through the lacrimal sac, through the hole, and into the nasal cavity. The ends of the silastic tube are then threaded through the passage in the insert. The insert is then placed from the nasal cavity into the hole by forcing the proximal end of the insert through the hole and into the lacrimal sac, and abutting the enlarged distal end, which is larger than the hole, against a surface in the nasal cavity surrounding the hole. The ends of the silastic tube are then fastened to the attachment element of the insert. Excess tube extending into the nasal cavity is then cut short to reduce nasal irritation. After the hole has sufficiently healed in about 3-6 months, the silastic tube and the insert are removed.

Method And System For Effecting Changes In Pigmented Tissue

US Patent:
2011028, Nov 17, 2011
Filed:
Jan 29, 2010
Appl. No.:
13/138260
Inventors:
Kambiz Thomas Moazed - New York NY, US
International Classification:
A61K 31/05
A61K 31/13
A61K 31/138
A61K 31/541
A61K 31/136
A61K 31/4178
A61K 31/47
A61K 31/485
A61K 31/7105
A61K 39/08
A61K 31/191
A61K 36/62
A61K 31/655
A61P 27/06
A61P 35/00
A61K 31/352
US Classification:
4242391, 514731, 514456, 514733, 514662, 514651, 5142278, 514648, 514397, 514734, 514307, 514282, 514 44 A, 514455, 514557, 424778, 514150
Abstract:
Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are nanoparticle compositions for lightening the pigmented tissues or treating a pigmented tissue related disease.

Method And System For Effecting Changes In Pigmented Tissue

US Patent:
2012007, Mar 29, 2012
Filed:
Jul 21, 2010
Appl. No.:
13/261047
Inventors:
Kambiz Thomas Moazed - New York NY, US
International Classification:
A61K 9/00
A61K 31/352
A61K 31/222
A61K 31/541
A61K 31/196
A61K 31/4178
A61K 31/472
A61K 31/485
A61K 31/13
A61K 31/713
A61K 38/16
A61K 36/185
A61K 31/23
A61K 31/557
A61K 31/655
A61K 31/136
C07F 3/06
A61P 27/02
A61P 43/00
A61P 27/06
A61P 35/00
A61K 31/05
B82Y 5/00
US Classification:
424427, 514731, 514733, 514456, 514546, 5142278, 514567, 514397, 514734, 514307, 514282, 514662, 514 44 A, 514 208, 514455, 424778, 514547, 514573, 514150, 514454, 514641, 556130, 977773, 977906
Abstract:
Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are nanoparticle compositions for lightening the pigmented tissues or treating a pigmented tissue related disease.

Method And System For Effecting Changes In Pigmented Tissue

US Patent:
2012020, Aug 16, 2012
Filed:
Nov 30, 2011
Appl. No.:
13/373797
Inventors:
Kambiz Thomas Moazed - New York NY, US
International Classification:
A61K 9/00
A61K 39/08
A61K 33/26
A61K 33/24
A61K 31/7088
A61K 31/13
A61K 31/05
A61P 27/06
A61P 35/00
A61P 27/02
A61K 8/40
A61K 31/352
B82Y 5/00
US Classification:
424427, 424 62, 4242391, 424641, 424646, 424649, 514 44 A, 514454, 514662, 514731, 977773, 977906
Abstract:
Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are compositions for lightening or darkening the pigmented tissues or treating a pigmented tissue disease.

Transnasal Lacrimal Insert

US Patent:
5993407, Nov 30, 1999
Filed:
Oct 25, 1996
Appl. No.:
8/736902
Inventors:
Kambiz Thomas Moazed - New York NY
International Classification:
A61M 500
US Classification:
604 8
Abstract:
A temporary transnasal lacrimal insert is used in a surgical procedure for improving drainage from a patient's lacrimal sac to his or her nasal cavity. The insert includes a tubular member with a proximal end and an enlarged distal end. The insert also includes an attachment element about which ends of a tube can be fastened. In the procedure, a hole is created extending from the lacrimal sac into the nasal cavity using surgical techniques or a laser probe. Then, opposite ends of a tube are introduced through the patient's upper and lower puncta, through the patient's upper and lower canaliculi, through the lacrimal sac, through the hole, and into the nasal cavity. The ends of the tube are then threaded through the passage in the insert. The insert is then placed from the nasal cavity into the hole by forcing the proximal end of the insert through the hole and into the lacrimal sac, and abutting the enlarged distal end, which is larger than the hole, against a surface in the nasal cavity surrounding the hole. The ends of the tube are then fastened to the attachment element of the insert.

Method And System For Effecting Changes In Pigmented Tissue

US Patent:
2019014, May 16, 2019
Filed:
Aug 3, 2017
Appl. No.:
15/731805
Inventors:
Kambiz Thomas Moazed - New York NY, US
International Classification:
A61K 45/06
A61Q 1/00
A61K 33/26
A61K 33/24
A61K 31/7088
A61K 9/00
A61K 31/13
A61K 31/05
A61K 31/352
Abstract:
Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are nanoparticle compositions for lightening or darkening the pigmented tissues or treating a pigmented tissue disease.

Possible Relatives

Kambiz Nazarian  Kambiz S Zomorrodi 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.